Christophe Blanquart

Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I

Geneviève Martin, Hélène Duez, Christophe Blanquart et al. · Journal of Clinical Investigation · 2001 · 418 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity

Olivier Barbier, Inès Pineda‐Torra, Audrey Sirvent et al. · Gastroenterology · 2003 · 199 citations

Life Sciences, Biochemistry, Pharmacology +17

Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator–Activated Receptor-α via Inhibition of the Protein Kinase C Signaling Pathway

Réjane Paumelle, Christophe Blanquart, Olivier Briand et al. · Circulation Research · 2006 · 162 citations

Medicine, Pharmacology, Pharmacotherapy +13

Peroxisome Proliferator-activated Receptor α (PPARα) Turnover by the Ubiquitin-Proteasome System Controls the Ligand-induced Expression Level of Its Target Genes

Christophe Blanquart, Olivier Barbier, Jean‐Charles Fruchart et al. · Journal of Biological Chemistry · 2002 · 155 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Human Lactoferrin Interacts with Soluble CD14 and Inhibits Expression of Endothelial Adhesion Molecules, E-Selectin and ICAM-1, Induced by the CD14-Lipopolysaccharide Complex

Sophie Baveye, Elisabeth Elass, David G. Fernig et al. · Infection and Immunity · 2000 · 148 citations

Life Sciences, Biochemistry, Immunology +17